Jefferies Financial Group Inc. Purchases 23,788 Shares of Cardinal Health, Inc. $CAH

Jefferies Financial Group Inc. grew its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 43.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 78,736 shares of the company’s stock after purchasing an additional 23,788 shares during the quarter. Jefferies Financial Group Inc.’s holdings in Cardinal Health were worth $16,180,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Aventura Private Wealth LLC acquired a new position in shares of Cardinal Health during the 4th quarter worth approximately $25,000. Jones Financial Companies Lllp increased its position in shares of Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after purchasing an additional 14,034 shares during the last quarter. JPL Wealth Management LLC acquired a new position in shares of Cardinal Health during the 3rd quarter worth approximately $31,000. Turning Point Benefit Group Inc. acquired a new position in shares of Cardinal Health during the 3rd quarter worth approximately $31,000. Finally, Cape Investment Advisory Inc. increased its position in shares of Cardinal Health by 61.1% during the 3rd quarter. Cape Investment Advisory Inc. now owns 211 shares of the company’s stock worth $33,000 after purchasing an additional 80 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Trading Down 0.1%

CAH stock opened at $200.42 on Monday. The firm has a market capitalization of $46.94 billion, a PE ratio of 30.64, a PEG ratio of 1.19 and a beta of 0.53. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $233.60. The business’s 50 day simple moving average is $205.21 and its 200 day simple moving average is $208.82.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The business had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm’s revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, sell-side analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Wednesday, July 1st. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is presently 31.19%.

Wall Street Analyst Weigh In

CAH has been the topic of several recent analyst reports. Leerink Partners reaffirmed an “outperform” rating and set a $275.00 price target on shares of Cardinal Health in a research report on Monday, March 9th. Zacks Research raised Cardinal Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 12th. Wall Street Zen raised Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, May 2nd. Morgan Stanley boosted their price target on Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 28th. Finally, Evercore lowered their price target on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 8th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $241.80.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.